Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that led to i.

Business Wire • Jun 24, 2026

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.

Zacks Investment Research • Jun 24, 2026

Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Jun 4, 2026

New Strong Sell Stocks for May 15th

AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.

Zacks Investment Research • May 15, 2026

Deciphering Avanos Medical (AVNS) International Revenue Trends

Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks Investment Research • May 11, 2026

AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down

Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.

Zacks Investment Research • May 7, 2026

Avanos Medical, Inc. Announces First Quarter 2026 Results

Delivered double-digit organic growth led by Specialty Nutrition Systems segment Generated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings per share On April 14, 2026, announced the execution of a definitive agreement to be acquired by certain affiliates of American Industrial Partners ("AIP") in an all-cash offer at an enterprise value of $1.272 billion ALPHARETTA, Ga., May 5, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2026 financial results.

PRNewsWire • May 5, 2026

Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.

Zacks Investment Research • May 5, 2026

Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, April 23, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Avanos (NYSE: AVNS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with American Industrial.

GlobeNewsWire • Apr 23, 2026

Top 2 Health Care Stocks That May Fall Off A Cliff In Q2

As of April 17, 2026, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga • Apr 17, 2026